Patent · US Expired

Mutant mycobacteria for use in therapy

US7122195B2 · kind B2 · utility

1Cited by

0References

14Claims

0Family size

Assignee

Erik C. Boettger · CH

Inventors

Eric Boettger · Zürich, CH
Peter Sander · Hamburg, DE
Burkhard Springer · Zürich, CH
Jo Colston, deceased · Westminster, GB

Key dates

Filing date	Dec 18, 2001
Grant date	Oct 17, 2006
Priority date	—
Expiry date	Sep 16, 2022

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12R2001/32
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This invention relates to recA mutant mycobacteria, particularly mutants of mycobacterial species which are members of the Mycobacterium tuberculosis complex, such as M. bovis BCG and M. tuberculosis. These mutant mycobacteria are useful as immunotherapteutic agents and vaccines for the treatment of a range of disorders, including tuberculosis.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.